You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海思科(002653.SZ)擬轉讓成都賽拉諾63.41%股權 聚焦新藥研發業務
格隆匯 09-29 19:48

格隆匯9月29日丨海思科(002653.SZ)公佈,公司持有成都賽拉諾醫療科技有限公司(以下簡稱“成都賽拉諾”)63.41%的股權,成都賽拉諾為公司控股子公司。基於成都賽拉諾經營現狀,為進一步優化資源配置、聚焦新藥研發業務,公司擬將所持有的上述成都賽拉諾股權轉讓給公司實際控制人王俊民和範秀蓮,其中王俊民受讓38.05%的股權,範秀蓮受讓25.36%的股權。股權轉讓總價為3.22億元人民幣,王俊民應支付轉讓價款為1.93億元人民幣,範秀蓮應支付轉讓價款為1.29億元人民幣。

相比藥品研發,公司在醫療器械領域的經驗不豐富,屬於公司較不擅長的領域,相比藥品研發的不確定性更大。成都賽拉諾致力於開發國際先進水平的介入式心臟瓣膜系統。基於以上原因,公司本次擬轉讓成都賽拉諾股權,通過本次交易公司可回籠前期已投入的資金且獲取一定收益,並能在未來更好的聚焦於以新藥研發為核心的主營業務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account